在内镜检查中,塞马格卢提德与胃内存的关联:回顾性分析
Garrick Han Gu1, Connor Pauplis2, Taylor Seacor1
1Internal Medicine, UMass Memorial Health, Worcester, United States.
赛马格卢提德是一种GLP-1激动剂,在内镜检查过程中显著增加了胃内存保留的风险. 使用塞马格卢提德减肥的患者面临的风险高于使用它治疗糖尿病的患者.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖类-1 (GLP-1) 激动剂,如塞马格卢提德,越来越多地用于糖尿病和体重管理.
- 这些药物对胃空化的作用以及对内镜手术的潜在影响仍然是人们感兴趣的领域.
研究的目的:
- 在食管胃二透镜 (EGD) 过程中,调查半谷氨酸治疗与留住的胃内容物 (RGC) 的存在之间的关联.
- 为了比较RGC的风险,患者使用西马格卢提德减肥与血糖控制.
主要方法:
- 采用了追溯病例控制研究设计.
- 接受GLP-1治疗的患者与对照组进行了比较,并使用倾向性得分匹配 (年龄,性别,BMI,EGD指示) 来匹配.
- 统计分析包括麦克纳马和曼-惠特尼测试.
主要成果:
- 在接受GLP-1治疗的患者 (12.5%) 与对照组 (1.3%) 相比,观察到显著更高的RGC率 (P < 0.0001).
- 使用塞马格卢提德减肥的患者的RGC率高于对照组 (23%) (P < 0.0001).
- 使用塞马格卢提德治疗糖尿病的患者的RGC率与对照组相似 (2.6%与对照组相比,P = 0.5).
结论:
- 在内镜检查期间,塞马格卢提德的使用与RGC的风险增加有关.
- 与用于血糖控制的患者相比,在使用塞马格卢提德减肥的患者中,RGC的风险似乎更高.
- 这些发现表明,在内镜手术前管理GLP-1激动剂的使用可能会产生临床影响.
更多相关视频
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
05:16Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
相关概念视频
Endoscopic Procedures III: Video Capsule Endoscopy
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
